BEAM
Price
$20.59
Change
-$0.39 (-1.86%)
Updated
Nov 20, 04:59 PM (EDT)
Capitalization
2.13B
103 days until earnings call
Intraday BUY SELL Signals
DNLI
Price
$17.16
Change
+$0.25 (+1.48%)
Updated
Nov 20, 04:59 PM (EDT)
Capitalization
2.48B
102 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs DNLI

Header iconBEAM vs DNLI Comparison
Open Charts BEAM vs DNLIBanner chart's image
Beam Therapeutics
Price$20.59
Change-$0.39 (-1.86%)
Volume$44.26K
Capitalization2.13B
Denali Therapeutics
Price$17.16
Change+$0.25 (+1.48%)
Volume$38.38K
Capitalization2.48B
BEAM vs DNLI Comparison Chart in %
BEAM
Daily Signal:
Gain/Loss:
DNLI
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BEAM vs. DNLI commentary
Nov 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and DNLI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 21, 2025
Stock price -- (BEAM: $20.99 vs. DNLI: $16.92)
Brand notoriety: BEAM and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 67% vs. DNLI: 90%
Market capitalization -- BEAM: $2.13B vs. DNLI: $2.48B
BEAM [@Biotechnology] is valued at $2.13B. DNLI’s [@Biotechnology] market capitalization is $2.48B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while DNLI’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 8 bearish.
  • DNLI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -4.02% price change this week, while DNLI (@Biotechnology) price change was -3.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.63%. For the same industry, the average monthly price growth was -6.94%, and the average quarterly price growth was +61.81%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

DNLI is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (-1.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.48B) has a higher market cap than BEAM($2.13B). BEAM YTD gains are higher at: -15.363 vs. DNLI (-16.977). BEAM has higher annual earnings (EBITDA): -414.33M vs. DNLI (-521.52M). BEAM has more cash in the bank: 1.15B vs. DNLI (899M). DNLI has less debt than BEAM: DNLI (46.6M) vs BEAM (155M). BEAM has higher revenues than DNLI: BEAM (60.3M) vs DNLI (0).
BEAMDNLIBEAM / DNLI
Capitalization2.13B2.48B86%
EBITDA-414.33M-521.52M79%
Gain YTD-15.363-16.97790%
P/E RatioN/AN/A-
Revenue60.3M0-
Total Cash1.15B899M128%
Total Debt155M46.6M333%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMDNLI
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
DNLI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CRFRX12.32N/A
N/A
Calvert Focused Value R6
WFEMX18.75N/A
N/A
WCM Focused Emerging Markets Investor
MVCJX31.44-0.07
-0.22%
MFS Mid Cap Value R4
JERSX11.92-0.09
-0.75%
Janus Henderson Global Real Estate S
RIVJX19.80-0.15
-0.75%
American Funds International Vntg R-5E